Erik Sjögren, Assoc. Prof., Ph.D.

Principal Consultant & PBPK-QSP Platform Science Lead

Bio

  • Joined Pharmetheus in 2017, actively working in client projects.
  • Expertise includes physiological based pharmacokinetic and biopharmaceutics modeling and simulation, clinical pharmacology, and pediatrics across therapeutic areas.
  • Experience as Researcher at Uppsala University, Sweden, where he has a part-time position to perform research and supervise Ph.D. students. Previously, he worked as Acting Senior Lecturer at Uppsala University, Sweden and Postdoctoral Researcher at AstraZeneca Mölndal, Sweden.
  • M.Sc. in Pharmaceutical Sciences (2004), Ph.D. in Pharmaceutical Sciences (2010), Associate Professor in Biopharmaceutics (2016) from Uppsala University, Sweden.
LinkedInGoogle Scholar

Pharmetheus affiliated publications

Open Systems Pharmacology Community-An Open Access, Open Source, Open Science Approach to Modeling and Simulation in Pharmaceutical SciencesMechanistic modelling of bioavailability and local immunogenicity after subcutaneous administration within the Open Systems Pharmacology frameworkPhysiologically-based pharmacokinetic modelling of recombinant factor IX Fc fusion protein (rFIXFc) and recombinant FIX (rFIX) to characterize extravasation and binding to type IV collagenLumenfantrine Exposure in Malnourished Children: PBPK Modeling Applied for Predictions and Dose AdjustmentsA Physiologically-Based Pharmacokinetic Framework for Prediction of Drug Exposure in Malnourished ChildrenOverview of Authorized Drug Products for Subcutaneous Administration: Pharmaceutical, Therapeutic, and Physicochemical PropertiesPhysiological Based Pharmacokinetic and Biopharmaceutics Modelling of Subcutaneously Administered Compounds – An Overview of In Silico ModelsA PBPK Framework to Predict Drug Exposure in Malnourished ChildrenApplications of Physiologically Based Biopharmaceutics Modeling (PBBM) to Support Drug Product Quality: A Workshop Summary ReportIn Vitro Biopredictive Methods: A Workshop Summary ReportBridging Physiologically Based Pharmacokinetic (PBPK) and Population Pharmacokinetic (PopPK) Analyses in Paediatric Drug Development: A Case Study Based on Intravenous Esomeprazole